1. Home
  2. JZXN vs OSRH Comparison

JZXN vs OSRH Comparison

Compare JZXN & OSRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

JZXN

Jiuzi Holdings Inc.

HOLD

Current Price

$1.84

Market Cap

16.2M

ML Signal

HOLD

Logo OSR Holdings Inc.

OSRH

OSR Holdings Inc.

HOLD

Current Price

$0.58

Market Cap

14.2M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
JZXN
OSRH
Founded
2019
N/A
Country
China
United States
Employees
N/A
N/A
Industry
Retail-Auto Dealers and Gas Stations
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
16.2M
14.2M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
JZXN
OSRH
Price
$1.84
$0.58
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
839.1K
721.5K
Earning Date
03-05-2026
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$97,465.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.58
$0.45
52 Week High
$312.80
$12.54

Technical Indicators

Market Signals
Indicator
JZXN
OSRH
Relative Strength Index (RSI) 54.78 45.79
Support Level $1.58 $0.54
Resistance Level $2.09 $0.69
Average True Range (ATR) 0.85 0.06
MACD -0.01 -0.01
Stochastic Oscillator 20.55 18.30

Price Performance

Historical Comparison
JZXN
OSRH

About JZXN Jiuzi Holdings Inc.

Jiuzi Holdings Inc operates as a franchise under the brand name Jiuzi. It sells new energy vehicles in third-fourth tier cities in China. The firm also sells plug-in electric vehicles on demand from vehicle buyers. Its operating segments are propretaey product; and resale of sourced Equipment and accessories from third party products. The company generates a majority of its revenue from the propretaey product segment. Geographically, the firm operates in China.

About OSRH OSR Holdings Inc.

OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.

Share on Social Networks: